These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1096801)

  • 1. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.
    Kaspar RL; Drutz DJ
    Antimicrob Agents Chemother; 1975 Apr; 7(4):462-5. PubMed ID: 1096801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple assay for 5-fluorocytosine in the presence of amphotericin B.
    Kauffman CA; Carleton JA; Frame PT
    Antimicrob Agents Chemother; 1976 Mar; 9(3):381-3. PubMed ID: 769677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK; Pankiewicz IJ
    Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified bioassay method for measurement of flucytosine or ketoconazole.
    Bodet CA; Jorgensen JH; Drutz DJ
    J Clin Microbiol; 1985 Aug; 22(2):157-60. PubMed ID: 4031030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid enzymatic method for measurement of serum flucytosine levels.
    Washburn RG; Klym DM; Kroll MH; Bennett JE
    J Antimicrob Chemother; 1986 May; 17(5):673-7. PubMed ID: 3522527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of yeasts to amphotericin B and 5-fluorocytosine.
    Abdul-Samad S; Arumugham G; Yasin MS
    Malays J Pathol; 1989 Aug; 11():37-42. PubMed ID: 2632999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
    Martin E; Maier F; Bhakdi S
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1331-8. PubMed ID: 8092834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine.
    Richardson MD; Paton M; Shankland GS
    Mycoses; 1991; 34(5-6):201-4. PubMed ID: 1795714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
    Beggs WH; Sarosi GA; Steele NM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):863-5. PubMed ID: 779631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of synergistic interactions between amphotericin B and flucytosine.
    Beggs WH
    J Antimicrob Chemother; 1986 Apr; 17(4):402-4. PubMed ID: 3519560
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function.
    Roselle GA; Kauffman CA
    Antimicrob Agents Chemother; 1978 Sep; 14(3):398-402. PubMed ID: 708017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.